InvestorsHub Logo
Followers 121
Posts 2016
Boards Moderated 0
Alias Born 11/20/2012

Re: None

Tuesday, 10/29/2013 12:15:58 PM

Tuesday, October 29, 2013 12:15:58 PM

Post# of 130508
After a long hot summer, I can say that LymPro diagnostic is well positioned to move into commercialization in 2014.

I have several friends at BioReference Labs in NJ who have been watching this
under the microscope and are now believers and investors.

The license to perform this test will generate between 100 to 200 million in sales in late 2014-2015 more then enough to accomplish a few of Gerald's milestones.

Critical point is to up list ASAP and he will need money on the books to do that.

Lets hope there is no reverse split along the way.
Stay long the course !!!